HealthDay writes about Todd Vogt, an OHSU patient with early-onset Parkinson’s disease who will compete for the U.S. in rowing during the Paralympic Games. Lauren Talman, M.D., says, “Todd is not just a remarkable athlete, but an inspiration to many. I will be cheering for him as a fan this summer in Paris, proud of how far he has come and excited to see what he accomplishes next.”

A Globe Newswire press release issued by the Chiesi Group announces that Maria Fleseriu, M.D., will present analysis of clinical trial results of an oral octreotide capsule in the treatment of acromegaly, a pituitary disorder.

Sanjay Malhotra, Ph.D., and Shivaani Kummar, M.D., are quoted in an OHSU News story about a first-of-its-kind drug that inhibits a protein that works as a signaling point in many different types of cancers, an example of the mission of the Center for Experimental Therapeutics in the OHSU Knight Cancer Institute. Kummar says, “The center was set up to bring discoveries from the lab to the clinic.”

In a UPI story about a survey revealing only half of U.S. residents have basic first aid training, Heather Wong, RN, endorses hands-only CPR, which, she says, “is less exhausting and easier to do if they are concerned about providing rescue breathing.”

Medscape covers promising results from a pilot study using focused ultrasound to create a lesion in the brain’s thalamus to treat trigeminal neuralgia, a painful chronic condition affecting a nerve in the face. Mary Heinricher, Ph.D., says, “Evidence that focused ultrasound targeting central lateral nucleus has the potential to provide relief is both a source of hope for these patients and likely tells us something about how this circuit has gone wrong. That information could put us on a path to better mechanistic understanding, which in turn, could lead to improved treatment.”

Wine Business Monthly highlights Hillsboro Medical Center’s longstanding ¡Salud! program to provide attainable, affordable health care to vine tenders with the support of the Hillsboro Medical Center Foundation. Leda Garside, RN, says, “We have our own mobile medical units, launched mobile mental health services by bilingual clinical psychologists, and established electronic medical records, which allows us, and other providers, to see services provided and follow-up plans.”

Scientific American republishes an Undark magazine story about a genetically engineered bacteria sold to prevent dental cavities. Jonathon Baker, Ph.D., notes that some bacteria, including Streptococcus mutans, can make both acid and biofilms — and that “it’s definitely possible” for this new, engineered bacteria to spread within families and cohabitating people.

In an Associated Press and CNHI News story about disparities in access to long-term assisted living facilities for people of color, Lindsey Smith says there is a lack of basic data about these facilities nationwide: “The federal government doesn’t even have a list of assisted living [facilities]. There is not a registration. When COVID hit, they did not have a list.”

A Portland rower and OHSU patient diagnosed with early onset Parkinson’s in 2018 has been selected to compete in the Paralympic Games this summer in Paris. He says, “I don’t want to be hyperbolic about it, but it’s going to be life-changing to be there. It’s going to be awesome."

An OHSU News story highlighting research led by Sanjay Malhotra, Ph.D., on a first-of-its-kind drug that inhibits a protein that works as a signaling point in many different types of cancers is picked up by MSN.com.